Inventor · disambiguated record
Markus Brechmann
Also filed as: BRECHMANN MARKUS
5 granted patents·1 pending application·10 citations·filing 2016–2024
70Inventor score
Top patents by PatentIndex Score
6 records- 0185US10435403B2Positive allosteric modulators of muscarinic M2 receptorBayer Pharma AG·Filed 2016·Granted Oct 8, 2019·7 cites·8 claims
- 0274US10519154B27-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereofBayer Pharma AG·Filed 2017·Granted Dec 31, 2019·2 cites·14 claims
- 0372US10927109B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2017·Granted Feb 23, 2021·1 cites·19 claims
- 0468US12357689B2Methods of treating or preventing a cardiovascular system complication of sickle cell disease with an anti-G-CSFR antibodyCSL Innovation Pty Ltd·Filed 2024·Granted Jul 15, 2025·0 cites·13 claims
- 0559US11472803B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2021·Granted Oct 18, 2022·0 cites·3 claims
- 0651US2019367516A1Positive allosteric modulators of muscarinic m2 receptorBayer Pharma AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Brechmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →